Goserelin Acetate (Zoladex)with or without Hormone Replacement Therapy for the Treatment of Endometriosis
- 30 June 1998
- journal article
- clinical trial
- Published by Elsevier BV in Fertility and Sterility
- Vol. 69 (6), 1056-1062
- https://doi.org/10.1016/s0015-0282(98)00086-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosisFertility and Sterility, 1995
- Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trialFertility and Sterility, 1995
- A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisteroneClinical Endocrinology, 1992
- Hormone treatment of endometriosis: The estrogenthreshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1992
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists?Journal of Clinical Endocrinology & Metabolism, 1990
- Long-Term Use of the Low Dose LHRH Analogue Combined With Monthly Medroxy-Progesterone AdministrationHormone Research, 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984